Piedmont Lithium Inc. (PLLTL)
| Previous close | 0.6600 |
| Open | 0.6228 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 0.6228 - 0.6600 |
| 52-week range | 0.0500 - 1.1205 |
| Volume | 490 |
| Avg. volume | 15,168 |
| Market cap | 988.346M |
| Beta (5Y monthly) | 0.46 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0150 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.35 |
- Editor's pickYahoo Finance Video
How the lithium shortage could impact EV production
Piedmont CEO Keith Phillips joins Yahoo Finance to discuss how his lithium plays a role in EV production
- GlobeNewswire
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Provention Bio, Danimer Scientific, AcelRX, and Piedmont Lithium on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors of Provention Bio, Inc. (NASDAQ: PRVB), Danimer Scientific, Inc. (NYSE: DNMR), AcelRX Pharmaceuticals, Inc. (NASDAQ: ACRX), and Piedmont Lithium Inc. (NASDAQ: PLL) on behalf of long-term stockholders. More information about each potential case can be found at the link provided. Provention Bio, Inc. (NASDAQ: PRVB) Bragar Eage
- Business Wire
Piedmont Increases Mineral Resources With Completion of Phase 5 Infill Drilling
BELMONT, N.C., October 21, 2021--Piedmont Lithium Inc. (Nasdaq: PLL) ("Piedmont" or "Company") is pleased to announce an updated global Mineral Resource estimate ("MRE") (Table 1 attached) for the Company’s flagship Carolina Lithium Project in North Carolina, USA. The MRE includes updates for lithium and industrial mineral products. The total MRE for the project is 44.2 Mt @ 1.08% Li2O, with 64% of the total MRE classified in the Indicated category. The Mineral Resource estimate reported in acco
